RS
IRMD icon

R Squared’s iRadimed IRMD Stock Holding History

R Squared’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,935
Closed -$286K – 576
2025
Q4 		$286K Sell
2,935
-1,395
-32% -$120K 0.13% 246
2025
Q3 		$308K Buy
+4,330
New +$289K 0.13% 242
2025
Q1 		– Sell
-540
Closed -$29.7K – 883
2024
Q4 		$29.7K Buy
+540
New +$28.4K 0.03% 713

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's IRMD Position: Q1 2026 in Review

R Squared sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 2,935 shares — an estimated $286K sold.

R Squared first reported a position in IRMD in Q4 2024 and held it in 3 quarters. The position peaked at $308K in Q3 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • R Squared reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • R Squared sold 2,935 iRadimed shares in Q1 2026, an estimated $286K.
  • R Squared first reported a position in iRadimed in Q4 2024 and held it in 3 quarters.
  • R Squared's iRadimed position peaked at $308K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.